Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16395130 | 0.90 | MITF (0.39) | MITFKMT2ACA1CA2CA9 | |
| SCHEMBL16394939 | 0.89 | KMT2A (0.37) | KMT2ACA1CA2CA9LMNA | |
| SCHEMBL16395266 | 0.88 | NPC1 (0.38) | KMT2ALMNAMEN1NPC1MAPK1 | |
| SCHEMBL16395073 | 0.86 | MITF (0.43) | MITFCA2LMNANPC1MAPK1 | |
| SCHEMBL16395100 | 0.83 | MAPK1 (0.39) | MITFKMT2ACA1CA2CA9 | |
| SCHEMBL16394862 | 0.83 | KMT2A (0.52) | KMT2ACA1CA2CA9LMNA | |
| SCHEMBL16395227 | 0.83 | MITF (0.39) | MITFLMNANPC1MAPK1CASP3 | |
| SCHEMBL16394874 | 0.82 | CA2 (0.46) | KMT2ACA1CA2CA9MEN1 | |
| SCHEMBL16394770 | 0.81 | KMT2A (0.37) | KMT2ACA1CA2CA9MEN1 | |
| SCHEMBL16395144 | 0.81 | MITF (0.43) | MITFCA2LMNANPC1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9780409-B2 | Nonaqueous electrolytic solution and nonaqueous-electrolyte battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20150024284-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150024284-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | TREH, SLC6A12, SCNN1G | MITF 3993/4885KMT2A 1699/4885CA1 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.